FDA could analyze public health consequences of its decisions better, experts say

A new report lays out a framework for the US Food and Drug Administration to systematically evaluate and compare the public health consequences of its decisions concerning a wide variety of products. Moreover, the risk-assessment framework provides a common internal language to discuss potential options and draws extensively on well-vetted risk literature to define the relevant health dimensions for FDA decision making.

Read the whole article on Science Daily

More from Science Daily